Physician

Dharmesh R Patel, MD

According to 2025 Medicare claims, Dharmesh Patel, MD (NPI: 1861488041) practices neurology in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is NEURO MEDICAL CARE ASSOCIATES PLLC (NPI: 1447335757; TIN: 161602141) and primary practice location at 13850-1559. Patel is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 734 traditional Medicare patients, billed 1,270 HCPCS/CPT codes, and received $122,002 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,921 prescription claims across 618 beneficiaries totaling $1,402,350 in drug costs, led by Xywav (Sodium,calcium,mag,pot Oxybate). DME data shows 4,357 claims. Open Payments data shows 27 records totaling $509. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $196,415 to $122,002. In contrast, Part D prescription costs have moved sharply higher in recent years, from $480,985 to $1,402,350. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	793	2,339	$196,415
2016	934	2,297	$207,293
2017	904	2,132	$195,446
2018	945	2,047	$174,116
2019	998	1,977	$177,442
2020	879	1,748	$137,155
2021	912	1,809	$169,241
2022	817	1,523	$140,395
2023	748	1,324	$125,675
2024	734	1,270	$122,002

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	327	2,199	$480,985
2016	355	2,414	$464,447
2017	396	2,688	$615,386
2018	432	2,737	$644,208
2019	488	2,787	$682,655
2020	514	3,150	$835,132
2021	577	3,303	$1,134,560
2022	579	3,736	$1,319,877
2023	574	3,548	$1,314,028
2024	618	3,921	$1,402,350

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,244	2,412	$156,659
2016	1,708	3,301	$120,700
2017	1,985	3,908	$102,678
2018	1,924	3,713	$106,379
2019	1,986	3,746	$103,144
2020	2,144	4,207	$149,043
2021	1,939	3,707	$145,684
2022	1,927	3,903	$156,771
2023	1,849	4,036	$185,224
2024	1,937	4,357	$158,712

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	410	488	$92
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	101	167	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	116	117	$66
95800	Sleep study including heart rate, breathing, and sleep time	65	68	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xywav	Sodium,calcium,mag,pot Oxybate	13	351	$174,609
Rebif Rebidose	Interferon Beta-1a/Albumin	12	336	$122,635
Betaseron	Interferon Beta-1b	11	308	$104,299
Nuplazid	Pimavanserin Tartrate	11	330	$52,090
Emgality Pen	Galcanezumab-Gnlm	35	1,854	$41,838

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	143	351	$31,231
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	184	425	$22,970
A7031	Face mask interface, replacement for full face mask, each	N	85	241	$21,256
A7032	Cushion for use on nasal mask interface, replacement only, each	N	71	160	$15,892
E0601	Continuous positive airway pressure (cpap) device	Y	77	430	$14,932

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$509	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dharmesh R. Patel, MD?

Tedicare shows public-source Medicare data for Dharmesh R. Patel, MD (NPI 1861488041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dharmesh R. Patel, MD have ACO affiliation data?

Dharmesh R. Patel, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Dharmesh R. Patel, MD?

Dharmesh R. Patel, MD is linked to NEURO MEDICAL CARE ASSOCIATES PLLC (billing NPI 1447335757) in the available physician profile data.

Does Dharmesh R. Patel, MD have Open Payments data?

Dharmesh R. Patel, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.